Evidence map›Paper›PMID 40011801›Full record

ArticleBMC bioinformatics2025

Combining single-cell ATAC and RNA sequencing for supervised cell annotation.

Jaidip Gill, Abhijit Dasgupta, Brychan Manry, Natasha Markuzon

Abstract read
In one paragraph

Article in BMC bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jaidip GillSchool of Public Health, Imperial College London, London, England.
Abhijit DasguptaOncology Data Science, AstraZeneca, Gaithersburg, MD, USA.
Brychan ManryOncology Data Science, AstraZeneca, Gaithersburg, MD, USA.
Natasha MarkuzonOncology Data Science, AstraZeneca, Waltham, MA, USA. natasha.markuzon@astrazeneca.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

motivationSingle-cell analysis offers insights into cellular heterogeneity and individual cell function. Cell type annotation is the first and critical step for performing such an analysis. Current methods mostly utilize single-cell RNA sequencing data. Several studies demonstrated improved unsupervised annotation when combining RNA with single-cell ATAC sequencing, but improvements in supervised methods have not been explored.

resultsSingle-cell 10x genomics multiome datasets containing paired ATAC and RNA from human peripheral blood mononuclear cells (PBMC) and neuronal cells with Alzheimer's Disease were used for supervised annotation. Using linear and nonlinear dimensionality reduction methods and random forest, support vector machine and logistic regression classification models, we demonstrate the improvement in supervised annotation and prediction confidence in PBMC data when using a combination of RNA seq and ATAC-seq data. No such improvement was observed when annotating neuronal cells. Specifically, F1 scores were improved when using scVI embeddings to annotate PBMC sub-types. CD4 T effector memory cells showed the largest improvement in F1 score.

Indexed as

Chromatin Immunoprecipitation SequencingSequence Analysis, RNASingle-Cell AnalysisAlzheimer DiseaseHumansLeukocytes, MononuclearMolecular Sequence AnnotationNeuronsSupport Vector MachineATACCell annotationMachine learningRNASingle-cell sequencing

Identifiers

PMID40011801
PMCPMC11863512

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.